Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

This study has been completed.
Information provided by (Responsible Party):
Bellerophon ( Bellerophon Pulse Technologies ) Identifier:
First received: November 13, 2012
Last updated: January 30, 2015
Last verified: January 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2014
  Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: January 30, 2015